Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Consolidated Net Income (2016 - 2025)

Sanara MedTech's Consolidated Net Income history spans 15 years, with the latest figure at -$502848.0 for Q4 2025.

  • For Q4 2025, Consolidated Net Income rose 80.92% year-over-year to -$502848.0; the TTM value through Dec 2025 reached -$37.0 million, down 362.82%, while the annual FY2025 figure was -$37.2 million, 366.18% down from the prior year.
  • Consolidated Net Income reached -$502848.0 in Q4 2025 per SMTI's latest filing, up from -$31.2 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $756914.0 in Q2 2022 to a low of -$31.2 million in Q3 2025.
  • Average Consolidated Net Income over 5 years is -$3.2 million, with a median of -$1.8 million recorded in 2024.
  • Peak YoY movement for Consolidated Net Income: skyrocketed 173.76% in 2022, then crashed 132615.77% in 2025.
  • A 5-year view of Consolidated Net Income shows it stood at -$3.6 million in 2021, then dropped by 17.06% to -$4.2 million in 2022, then soared by 93.7% to -$262444.0 in 2023, then plummeted by 904.14% to -$2.6 million in 2024, then skyrocketed by 80.92% to -$502848.0 in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Consolidated Net Income are -$502848.0 (Q4 2025), -$31.2 million (Q3 2025), and -$1.8 million (Q2 2025).